Abstract:The reaction of the vanadyl ion (VO2+) with imidazole-4-carboxylic acid (Im4COOH), imidazole-2-carboxylic acid (Im2COOH) and methylimidazole-2-carboxylic acid (MeIm2COOH), respectively, in the presence of small bioligands (bL) [oxalate (Ox), lactate (Lact), citrate (Cit) and phosphate (Phos)] and high-molecular-weight (HMW) human serum proteins [albumin (HSA) and transferrin (hTf)] were studied in aqueous solution using potentiometric acid–base titrations. The species distribution diagrams for the high-molecular-mass (HMM) proteins with oxidovanadium(IV) under physiological pH were dominated by VO(HMM)2, VOL(HMM) for unsubstituted ligands (L− = Im4COO− and Im2COO−). However, for the N-substituted MeIm2COOH, the species distribution diagrams under physiological pH were dominated by VOL2, VO(HMM)2 and VO2L2(HMM). These species were further confirmed by LC-MS, MALDI-TOF-MS and EPR studies. The glucose-stimulated insulin secretion (GSIS) action of the complexes was investigated using INS-1E cells at a 1 μM concentration, which was established through cytotoxicity studies via the MTT assay. The neutral complexes, especially VO(MeIm2COO)2, showed promising results in the stimulation of insulin secretion than the cationic [VO(MeIm2CH2OH)2]2+ complex and the vanadium salt. Oxidovanadium(IV) complexes reduced insulin stimulation significantly under normoglycaemic levels but showed positive effects on insulin secretion under hyperglycaemic conditions (33.3 mM glucose media). The islets exposed to oxidovanadium(IV) complexes under hyperglycaemic conditions displayed a significant increase in the stimulatory index with 1.19, 1.75, 1.53, 1.85, 2.20 and 1.29 observed for the positive control (sulfonylurea:gliclazide), VOSO4, VO(Im4COO)2, VO(Im2COO)2, VO(MeIm2COO)2 and VO(MeIm2CH2OH)22+, respectively. This observation showed a potential further effect of vanadium complexes towards type 2 diabetes and has been demonstrated for the first time in this study.

Effects of insulin-mimetic vanadyl-poly(γ-glutamic acid) complex on diabetic rat model

Effects of insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex on diabetic rat model.

Synthesis And Anti-Diabetic Activity Of New N,N-Dimethylphenylenediamine-Derivatized Nitrilotriacetic Acid Vanadyl Complexes

Pharmacodynamics and Pharmacokinetics of the Insulin-Mimetic Agent Vanadyl Acetylacetonate in Non-Diabetic and Diabetic Rats.

Effects of Bis(α-Furancarboxylato)oxovanadium(iv) on Glucose Metabolism in Fat-Fed/streptozotocin-diabetic Rats

A Non-Toxic Binuclear Vanadium(IV) Complex as Insulin Adjuvant Improves the Glycemic Control in Streptozotocin-Induced Diabetic Rats

A New Orally Active Antidiabetic Vanadyl Complex – Bis(α-Furancarboxylato)oxovanadium(iv)

Therapeutic Effect of Vanadyl Rosiglitazone on Diabetic Mice

Hypoglycemic Properties of Oxovanadium (IV) Coordination Compounds with Carboxymethyl-Carrageenan and Carboxymethyl-Chitosan in Alloxan-Induced Diabetic Mice

Effective Control of Blood Glucose Status and Toxicity in Streptozotocin-Induced Diabetic Rats by Orally Administration of Vanadate in an Herbal Decoction

Antidiabetic effects and mechanism of γ-polyglutamic acid on type II diabetes mice

Ganoderma Lucidum Polysaccharides Exert Anti-Hyperglycemic Effect On Streptozotocin-Induced Diabetic Rats Through Affecting Beta-Cells

A New Oxovanadium Complex Enhances Renal Function by Improving Insulin Signaling Pathway in Diabetic Mice.

[Modulation Effect of Bis (Alpha-Furancarboxylato) Oxovanadium (IV) on Blood Glucose in Diabetic Rats].

Ameliorative effect of vanadyl(IV)–ascorbate complex on high-fat high-sucrose diet-induced hyperglycemia, insulin resistance, and oxidative stress in mice

A Novel PTP1b Inhibitor Vanadium-Flavone Complex: Synthesis and Pharmacodynamic Evaluation in Streptozotocin-Induced Diabetic Mice

Biospeciation of Oxidovanadium(IV) Imidazolyl–Carboxylate Complexes and Their Action on Glucose-Stimulated Insulin Secretion in Pancreatic Cells

Synthesis, characterization and anti-diabetic therapeutic potential of novel aminophenol-derivatized nitrilotriacetic acid vanadyl complexes

Synthesis, Characterization and Anti-Diabetic Therapeutic Potential of a New Benzyl Acid-Derivatized Kojic Acid Vanadyl Complex

Vanadium Compounds Modulate PPARγ Activity Primarily by Increasing PPARγ Protein Levels in Mouse Insulinoma NIT-1 Cells

The Anti-Diabetic Effects and Pharmacokinetic Profiles of Bis(maltolato)oxovanadium in Non-Diabetic and Diabetic Rats.